[1] Cheng Y, Shi D, Xu Z, et al. 124I-Labeled Monoclonal Antibody and Fragment for the Noninvasive Evaluation of Tumor PD-L1 Expression In Vivo [published online ahead of print, 2022 Mar 4]. Mol Pharm. 2022;10.1021/acs.molpharmaceut.2c00084. doi:10.1021/acs.molpharmaceut.2c00084(IF:4.939)